Reduction of N-acetylaspartate in the medial prefrontal cortex correlated with symptom severity in obsessive-compulsive disorder: Meta-analyses of 1 H-MRS studies

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Aoki, Yuta ^a   Aoki, Ai ^a   Suwa, Hiroshi ^a  

^a Department of Dentistry Oral surgery   (Japan)

Author keywords

cortico striato thalamo cortical circuity; MRS; N acetylaspartate (NAA); obsessive compulsive disorder (OCD); systematic review

Indexed keywords

N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ARTICLE; BASAL GANGLION; BRAIN REGION; DISEASE SEVERITY; HUMAN; MEDIAL PREFRONTAL CORTEX; META ANALYSIS (TOPIC); NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; THALAMUS; YALE BROWN OBSESSIVE COMPULSIVE SCALE; META ANALYSIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEVERITY OF ILLNESS INDEX;

ASPARTIC ACID; BASAL GANGLIA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE-COMPULSIVE DISORDER; PREFRONTAL CORTEX; SEVERITY OF ILLNESS INDEX; THALAMUS;

EID: 84874292505     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.78     Document Type: Article

References (69)

1. Bonelli RM, Cummings JL. Frontal-subcortical circuitry and behavior. Dialogues Clin Neurosci 2007; 9: 141-151.
2. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008; 32: 525-549.
3. Martinot JL, Allilaire JF, Mazoyer BM, Hantouche E, Huret JD, Legaut-Demare F et al. Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta Psychiatrica Scandinavica 1990; 82: 233-242.
4. Mcguire PK, Bench CJ, Frith CD, Marks IM, Frackowiak RS, Dolan RJ. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994; 164: 459-468.
5. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Se S et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry 1995; 166: 244-250.
6. Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET et al. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res 2000; 99: 15-27.
7. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry 2005; 57: 901-910.
8. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 564-576.
9. Rauch SL, Wedig MM, Wright CI, Martis B, McMullin KG, Shin LM et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007; 61: 330-336.
10. Nakao T, Nakagawa A, Yoshiura T, Nakatani E, Nabeyama M, Yoshizato C et al. A functional MRI comparison of patients with obsessive-compulsive disorder and normal controls during a Chinese character Stroop task. Psychiatry Res 2005; 139: 101-114.
11. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJLM, van Hartskamp J et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arc Gen psychiatry 2005; 62: 301-309.
12. Remijnse PL, Nielen MMA, van Balkom AJLM, Cath DC, van Oppen P, Uylings HBM et al. Reduced orbitofrontal-striatal activity on a reversal learning task in obsessive-compulsive disorder. Arch Gen Psychiatry 2006; 63: 1225-1236.
13. Valente AA Jr, Miguel EC, Castro CC, Amaro E Jr, Duran FL, Buchpiguel CA et al. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry 2005; 58: 479-487.
14. Radua J, Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry 2009; 195: 393-402.
15. Rotge J-Y, Guehl D, Dilharreguy B, Tignol J, Bioulac B, Allard M et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry 2009; 65: 75-83.
16. Braber den A, Ent DV, Boomsma DI, Cath DC, Veltman DJ, Thompson PM et al. White matter differences in monozygotic twins discordant or concordant for obsessive-compulsive symptoms: a combined diffusion tensor imaging/voxel-based morphometry study. Biol Psychiatry 2011; 70: 969-977.
17. Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998; 10: 133-147.
18. De Graaf RA. In vivo NMR spectroscopy. Principles and Techniques. Wiley-Interscience. John Wiley & Sons Ltd: Chichester, UK, 2008.
19. Merkl A, Schubert F, Quante A, Luborzewski A, Brakemeier E-L, Grimm S et al. Abnormal cingulate and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biol Psychiatry 2011; 69: 772-779.
20. Clarke CE, Lowry M, Horsman A. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Mov Disord 1997; 12: 297-301.
21. Baslow MH. Evidence that the tri-cellular metabolism of N-acetylaspartate functions as the brain's 'operating system': how NAA metabolism supports meaningful intercellular frequency-encoded communications. Amino Acids 2010; 39: 1139-1145.
22. Jang JH, Kwon JS, Jang DP, Moon W-J, Lee J-M, Ha TH et al. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Am J Psychiatry 2006; 163: 1202-1207.
23. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004; 43: 1146-1153.
24. Fan Q, Tan L, You C, Wang J, Ross CA, Wang X et al. Increased N-Acetylaspartate/creatine ratio in the medial prefrontal cortex among unmedicated obsessive-compulsive disorder patients. Psychiatry Clin Neurosci 2010; 64: 483-490.
25. Aoki Y, Inokuchi R, Gunshin M, Yahagi N, Suwa H. Diffusion tensor imaging studies of mild traumatic brain injury: a meta-analysis. J Neurol Neurosurg Psychiatry 2012; PMID: 22797288 (in press).
26. Kitamura H, Shioiri T, Kimura T, Ohkubo M, Nakada T, Someya T. Parietal white matter abnormalities in obsessive-compulsive disorder: a magnetic resonance spectroscopy study at 3-tesla. Acta Psychiatr Scand 2006; 114: 101-108.
27. Sumitani S, Harada M, Kubo H, Ohmori T. Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. Psychiatry Res 2007; 154: 85-92.
28. Mohamed MA, Smith MA, Schlund MW, Nestadt G, Barker PB, Hoehn-Saric R. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: a pilot investigation comparing treatment responders and non-responders. Psychiatry Res 2007; 156: 175-179.
29. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
30. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Wiley: Chichester, UK, 2008.
31. Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J et al. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry 2008; 42: 467-477.
32. Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J et al. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry 2007; 64: 946-955.
33. Fornito A, Yung AR, Wood SJ, Phillips LJ, Nelson B, Cotton S et al. Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry 2008; 64: 758-765.
34. Ebert D, Speck O, König A, Berger M, Hennig J, Hohagen F. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Res 1997; 74: 173-176.
35. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Res 1999; 92: 83-91.
36. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000; 39: 1096-1103.
37. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol 2001; 16: 636-641.
38. Mirza Y, O'Neill J, Smith EA, Russell A, Smith JM, Banerjee SP et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol 2006; 21: 106-111.
39. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 2006; 146: 137-147.
40. Scherk H, Backens M, Schneider-Axmann T, Kraft S, Kemmer C, Usher J et al. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen. World J Biol Psychiatry 2009; 10: 524-530.
41. Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T et al. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. J Neural Transm 2008; 115: 1051-1062.
42. Besiroglu L, Sozen M, Ozbebit O, Avcu S, Selvi Y, Bora A et al. The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions. Acta Psychiatr Scand 2011; 124: 141-151.
43. Bédard M-J, Chantal S. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression. Psychiatry Res 2011; 192: 45-54.
44. Benazon NR, Moore GJ, Rosenberg DR. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry 2003; 42: 1279-1285.
45. Scherk H, Backens M, Zill P, Schneider-Axmann T, Wobrock T, Usher J et al. SNAP-25 genotype influences NAA/Cho in left hippocampus. J Neural Transm 2008; 115: 1513-1518.
46. Arnold PD, Macmaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E et al. Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder. Psychiatry Res 2009; 172: 136-139.
47. Trzesniak C, Araújo D, Crippa JAS. Magnetic resonance spectroscopy in anxiety disorders. Acta Neuropsychiatr 2008; 20: 56-71.
48. Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J et al. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry 2003; 54: 1399-1405.
49. Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 2000; 47: 174-182.
50. Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ et al. A short echo 1 H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. Am J Psychiatry 1998; 155: 1584-1591.
51. Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci 2009; 63: 486-490.
52. Brugger S, Davis JM, Leucht S, Stone JM. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biol Psychiatry 2011; 69: 495-503.
53. Aoki Y, Kasai K, Yamasue H. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies. Transl Psychiatry 2012; 2: e69.
54. Yildiz-Yesiloglu A, Ankerst DP. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res Neuroimaging 2006; 147: 1-25.
55. Wang Y, Jia Y, Xu G, Ling X, Liu S, Huang L. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study. J Affect Disord 2012; 136: 620-626.
56. Bates TE, Strangward M, Keelan J, Davey GP, Munro PM, Clark JB. Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996; 7: 1397-1400.
57. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007; 81: 89-131.
58. Janson CG, McPhee SWJ, Francis J, Shera D, Assadi M, Freese A et al. Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics 2006; 37: 209-221.
59. Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G et al. Intravenous ethanol infusion decreases human cortical g-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry 2012; 71: 239-246.
60. Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 2002; 13: 2133-2137.
61. Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS. Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 2003; 14: 347-353.
62. Stern ER, Welsh RC, Fitzgerald KD, Gehring WJ, Lister JJ, Himle JA et al. Hyperactive error responses and altered connectivity in ventromedial and frontoinsular cortices in obsessive-compulsive disorder. Biol Psychiatry 2011; 69: 583-591.
63. Fitzgerald KD, Stern ER, Angstadt M, Nicholson-Muth KC, Maynor MR, Welsh RC et al. Altered function and connectivity of the medial frontal cortex in pediatric obsessive-compulsive disorder. Biol Psychiatry 2010; 68:1039-1047.
64. Greenspan JD, Coghill RC, Gilron I, Sarlani E, Veldhuijzen DS, Lenz FA. Quantitative somatic sensory testing and functional imaging of the response to painful stimuli before and after cingulotomy for obsessive-compulsive disorder (OCD). Eur J Pain 2008; 12:990-999.
65. Luigjes J, de Kwaasteniet BP, de Koning PP, Oudijn MS, van den Munckhof P, Schuurman PR et al. Surgery for psychiatric disorders. World Neurosurg; PMID: 22465369 (in press).
66. Laplane D, Levasseur M, Pillon B, Dubois B, Baulac M, Mazoyer B et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989; 112: 699-725.
67. Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J et al. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry 2008; 165:1308-1315.
68. Nakao T, Nakagawa A, Nakatani E, Nabeyama M, Sanematsu H, Yoshiura T et al. Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res 2009; 43: 784-791.
69. Schuff N, Neylan TC, Fox-Bosetti S, Lenoci M, Samuelson KW, Studholme C et al. Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 2008; 162:147-157.